Analyst Geoff Porges of Leerink Partners discussed Medivation Inc’s (NASDAQ:MDVN) pipeline drug, talazoparib, after listening into a conference call sponsored by the company. On the …
After joining Leerink Partners in November, analyst Geoff Porges reinitiated coverage yesterday on major healthcare stocks. Among the equities in focus are pharmaceutical giants Gilead Sciences, Inc.
